Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.88 USD | -0.88% | -4.33% | -6.84% |
Mar. 13 | Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM | |
Feb. 05 | North American Morning Briefing : Hopes of March -2- | DJ |
Financials (USD)
Sales 2024 * | 1.15B | Sales 2025 * | 1.25B | Capitalization | 11.3B |
---|---|---|---|---|---|
Net income 2024 * | 177M | Net income 2025 * | 226M | EV / Sales 2024 * | 10 x |
Net Debt 2024 * | 187M | Net cash position 2025 * | 14.16M | EV / Sales 2025 * | 9.04 x |
P/E ratio 2024 * |
65.3
x | P/E ratio 2025 * |
51
x | Employees | 3,050 |
Yield 2024 * |
0.45% | Yield 2025 * |
0.45% | Free-Float | 99.64% |
Latest transcript on Bio-Techne Corporation
1 day | -0.88% | ||
1 week | -4.33% | ||
Current month | -2.30% | ||
1 month | +0.38% | ||
3 months | -5.45% | ||
6 months | +1.00% | ||
Current year | -6.84% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 18-04-29 |
James Hippel
DFI | Director of Finance/CFO | 53 | 14-03-31 |
Matthew McManus
COO | Chief Operating Officer | 55 | Jan. 07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 02-12-31 | |
Randolph Steer
BRD | Director/Board Member | 74 | 89-12-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 17-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | -.--% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 71.88 | -0.88% | 1,004,049 |
24-03-15 | 72.52 | +1.83% | 1,749,508 |
24-03-14 | 71.22 | -1.75% | 1,380,383 |
24-03-13 | 72.49 | -2.20% | 995,750 |
24-03-12 | 74.12 | -1.34% | 1,105,193 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.84% | 11.3B | |
+9.72% | 46.21B | |
+35.14% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
+6.40% | 11.01B |